| 1. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1074,
1997,
Page 2-2
&NA;,
Preview
|
PDF (1141KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
| 2. |
US FDA news in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1074,
1997,
Page 3-3
&NA;,
Preview
|
PDF (1052KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
| 3. |
Recommendations from the AAP |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1074,
1997,
Page 4-4
&NA;,
Preview
|
PDF (1105KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
| 4. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1074,
1997,
Page 5-5
&NA;,
Preview
|
PDF (1081KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
| 5. |
Hidden costs of meropenemvsimipenem/cilastatin assessed |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1074,
1997,
Page 6-6
&NA;,
Preview
|
PDF (1133KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
| 6. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1074,
1997,
Page 7-7
&NA;,
Preview
|
PDF (1046KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
| 7. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1074,
1997,
Page 8-8
&NA;,
Preview
|
PDF (1071KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
| 8. |
High hopes for Cel-Sci's ‘LEAPS’ vaccine technology |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1074,
1997,
Page 9-10
Gill Higgins,
Preview
|
PDF (2175KB)
|
|
摘要:
The aim of research at Cel-Sci is to develop vaccines that can improve the fighting capacity of the immune system by stimulating selected immune cells. Cel-Sci is hopeful that this can be achieved using the company's ligandepitope-antigen presentation system (‘LEAPS’) vaccine technology. One of the potential advantages of this technology is that it may alleviate the need for a carrier protein, thus simplifying the manufacturing process and reducing costs. The company hopes that this technology will be suitable for developing vaccines against viruses, bacteria and parasites, as well as those for use in cancer, autoimmune and allergic indications. Cel-Sci's vicepresident of research Dr Daniel Zimmerman toldInpharma®that the company is‘very excited’about progress to date, particularly regarding the vaccines under development for the treatment of HIV infection.
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
| 9. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1074,
1997,
Page 10-10
&NA;,
Preview
|
PDF (1116KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
| 10. |
C-reactive protein levels could guide antibacterial treatment |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1074,
1997,
Page 11-11
&NA;,
Preview
|
PDF (990KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
首页
